ConductScience.org, home

Paper41282147

Calcitriol and hyperthermia potentiate gemcitabine efficacy - A Multifactorial Preclinical Evaluation in Pancreatic and Breast Cancer.

Wiecheć-Cudak O and 10 others. Res Sq, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Calcitriol and hyperthermia potentiate gemcitabine efficacy - A Multifactorial Preclinical Evaluation in Pancreatic and Breast Cancer. Papers, record 41282147. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41282147

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Calcitriol and hyperthermia potentiate gemcitabine efficacy - A Multifactorial Preclinical Evaluation in Pancreatic and Breast Cancer.
PubMed
Journal
Res Sq
PubMed
Year
2025
PubMed
Publication types
Journal Article, Preprint
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-09-18
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wiecheć-Cudak OOlga
2Murzyn AAleksandra
3Drwięga GGniewosz
4Bienia AAleksandra
5Kłóś AAdam
6Robak DDominik
7Urbańska KKrystyna
8Stanimirova-Daszykowska IIvana
9Słomiński ATAndrzej T
10Elas MMartyna
11Krzykawska-Serda MMartyna

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 AR073004NIAMS NIH HHSUnited StatesR01AR073004PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120138989Heat shock protein 90 interacts with vitamin D receptor in human leukemia cells.J Steroid Biochem Mol Biol2010https://conductscience.org/library/papers/20138989PubMed
228885916Calcitriol Reverses Induced Expression of Efflux Proteins and Potentiates Cytotoxic Activity of Gemcitabine in Capan-2 Pancreatic Cancer Cells.J Pharm Pharm Sci2017https://conductscience.org/library/papers/28885916PubMed
328410237Combination therapy in combating cancer.Oncotarget2017https://conductscience.org/library/papers/28410237PubMed
415681024Overcoming limitations of natural anticancer drugs by combining with artificial agents.Trends Pharmacol Sci2005https://conductscience.org/library/papers/15681024PubMed
526949479Searching for Drug Synergy in Complex Dose-Response Landscapes Using an Interaction Potency Model.Comput Struct Biotechnol J2015https://conductscience.org/library/papers/26949479PubMed
640416168Targeting ERβ1-Positive Triple-Negative Breast Cancer: Molecular Effects of Calcitriol and 17β-Estradiol.Cureus2025https://conductscience.org/library/papers/40416168PubMed
722594894New vitamin D analogs as potential therapeutics in melanoma.Expert Rev Anticancer Ther2012https://conductscience.org/library/papers/22594894PubMed
825558828A synthetic lethal screen identifies the Vitamin D receptor as a novel gemcitabine sensitizer in pancreatic cancer cells.Cell Cycle2014https://conductscience.org/library/papers/25558828PubMed
927865536Breast cancer.Lancet2017https://conductscience.org/library/papers/27865536PubMed
1038927967Malignant Melanoma: An Overview, New Perspectives, and Vitamin D Signaling.Cancers (Basel)2024https://conductscience.org/library/papers/38927967PubMed
1115585396Caspase-3 drives apoptosis in pancreatic cancer cells after treatment with gemcitabine.J Gastrointest Surg2004https://conductscience.org/library/papers/15585396PubMed
1229763773Ultrasound Doppler as an Imaging Modality for Selection of Murine 4T1 Breast Tumors for Combination Radiofrequency Hyperthermia and Chemotherapy.Transl Oncol2018https://conductscience.org/library/papers/29763773PubMed
1322690925Old and new facts about hyperthermia-induced modulations of the immune system.Int J Hyperthermia2012https://conductscience.org/library/papers/22690925PubMed
1420164683Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy.Cancer J2010https://conductscience.org/library/papers/20164683PubMed
1531892603Relevance of Vitamin D in Melanoma Development, Progression and Therapy.Anticancer Res2020https://conductscience.org/library/papers/31892603PubMed
1630968156Vitamin D and its low calcemic analogs modulate the anticancer properties of cisplatin and dacarbazine in the human melanoma A375 cell line.Int J Oncol2019https://conductscience.org/library/papers/30968156PubMed
1728676457On the role of classical and novel forms of vitamin D in melanoma progression and management.J Steroid Biochem Mol Biol2018https://conductscience.org/library/papers/28676457PubMed
182116003020-Hydroxyvitamin D2 is a noncalcemic analog of vitamin D with potent antiproliferative and prodifferentiation activities in normal and malignant cells.Am J Physiol Cell Physiol2011https://conductscience.org/library/papers/21160030PubMed
1926445902Detection of novel CYP11A1-derived secosteroids in the human epidermis and serum and pig adrenal gland.Sci Rep2015https://conductscience.org/library/papers/26445902PubMed
2023662149Hyperthermia versus Oncothermia: Cellular Effects in Complementary Cancer Therapy.Evid Based Complement Alternat Med2013https://conductscience.org/library/papers/23662149PubMed

See all 48 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41282147

GET https://conductscience.org/api/papers/v1/41282147/references?page=2